Accelerated atherosclerosis and elevated lipoprotein (a) after liver transplantation

Abdulla A. Damluji, Diala El-Maouche, Ali Alsulaimi, Paul Martin, Robert D. Shamburek, Ronald B Goldberg, Seth J. Baum, Eduardo De Marchena

Research output: Contribution to journalArticle

3 Scopus citations


Cumulative evidence suggests that lipoprotein(a) [Lp(a)] exerts an independent effect on the initiation and progression of atherosclerotic cardiovascular disease. The genetically mediated expression of apolipoprotein(a), which is the key structural and functional component of Lp(a), occurs in hepatocytes with subsequent extracellular Lp(a) assembly at the hepatic cell surface. Here, we describe a case of elevated Lp(a) concentrations identified after (and likely acquired by) orthotopic liver transplantation that contributed to accelerated atherosclerotic cardiovascular disease despite intensive therapeutic interventions. This case study represents an important example to include Lp(a) screening in routine lipid panel testing for all liver transplant donors and recipients; to reduce unanticipated and debilitating cardiovascular morbidity and mortality.

Original languageEnglish (US)
JournalJournal of Clinical Lipidology
StateAccepted/In press - May 24 2015


  • Cardiovascular disease
  • Lipids
  • Lp(a)
  • Prevention
  • Therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'Accelerated atherosclerosis and elevated lipoprotein (a) after liver transplantation'. Together they form a unique fingerprint.

  • Cite this